Influence of cerebrospinal fluid drainage and other variables on the plasma vancomycin trough levels in postoperative neurosurgical patients

References

• National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–85.
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Zhong HL, Wang ZM, Zhao F, Liu PN. Prevention of postoperative intracranial infection in patients with cerebrospinal fluid rhinorrhea. Chin Med J 2011; 124:4189–92.
   PubMed Web of Science ®Google Scholar
• Arabi Y, Memish ZA, Balkhy HH, et al. Ventriculostomy-associated infections: incidence and risk factors. Am J Infect Control 2005; 33:137–43.
   PubMed Web of Science ®Google Scholar
• Vandecasteele SJ, De Vriese AS. Recent changes in vancomycin use in renal failure. Kidney Int 2010; 77:760–4.
   PubMed Web of Science ®Google Scholar
• Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66:82–98.
   PubMedGoogle Scholar
• Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol 2012; 68:1243–55.
   PubMed Web of Science ®Google Scholar
• Matzke GR, Zhanel GG, Guay DR. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet 1986; 11:257–82.
   PubMed Web of Science ®Google Scholar
• Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009;49:507–14.
   PubMed Web of Science ®Google Scholar
• Lu H, Tang L, Xue S, et al. [Clinical verification of vancomycin population pharmacokinetics in patients with augmented renal clearance]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2018;30:444–8.
   PubMedGoogle Scholar
• Kullar R, Davis SL, Levine DP, Rybak MJ. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis 2011;52:975–81.
   PubMed Web of Science ®Google Scholar
• Murthy SB, Moradiya Y, Shah J, Hanley DF, Ziai WC. Incidence, predictors, and outcomes of ventriculostomy-associated infections in spontaneous intracerebral hemorrhage. Neurocrit Care 2016;24:389–96.
   PubMed Web of Science ®Google Scholar
• Pujal M, Soy D, Codina C, Ribas J. Are higher vancomycin doses needed in ventricle-external shunted patients. Pharm World Sci 2006;28:215–21.
   PubMedGoogle Scholar
• Lutsar I, McCracken GH, Jr, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 1998;27:1117–27. quiz 1128–9.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Jafri H, Lutsar I, et al. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1999;43:876–81.
   PubMed Web of Science ®Google Scholar
• Andes DR, Craig WA. Pharmacokinetics and pharmacodynamics of antibiotics in meningitis. Infect Dis Clin North Am 1999;13:595–618.
   PubMed Web of Science ®Google Scholar
• Albanèse J, Léone M, Bruguerolle B, Ayem M-L, Lacarelle B, Martin C, Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother 2000;44:1356–8.
   PubMed Web of Science ®Google Scholar
• Roland N, Fritz S, Helmut E. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010;23:858–83.
   PubMed Web of Science ®Google Scholar
• Pfausler B, Spiss H, Beer R, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 2003;98:1040–4.
   PubMed Web of Science ®Google Scholar
• Wang Q, Shi Z, Wang J, Shi G, Wang S, Zhou J. Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients. Surg Neurol 2008;69:126–9; discussion 129.
   PubMedGoogle Scholar
• Lodise TP, Graves J, Evans A, et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. AAC 2008;52:3315–20.
   Google Scholar
• Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006;166:2138–44.
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC, Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004;42:2398–402.
   PubMed Web of Science ®Google Scholar
• Othman HB, Halim R, Gomaa F, Amer MZ. Vancomycin MIC distribution among methicillin-resistant Staphylococcus aureus. Is reduced vancomycin susceptibility related to MIC Creep. Open Access Maced J Med Sci 2019;7:12–8.
   PubMedGoogle Scholar
• Lin CY, Wang JH, Lin KH, Ho YL, Ho CM. Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan. Ci Ji Yi Xue Za Zhi 2018;30:135–40.
   PubMedGoogle Scholar
• Sullivan SB, Austin ED, Stump S, et al. Reduced vancomycin susceptibility of methicillin-susceptible Staphylococcus aureus has no significant impact on mortality but results in an increase in complicated infection. Antimicrob Agents Chemother 2017; 61:e00316–17.
   PubMed Web of Science ®Google Scholar
• Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003;47:3040–5.
   PubMed Web of Science ®Google Scholar
• Ankomah P, Levin BR. Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections. Proc Natl Acad Sci U S A 2014;111:8331–8.
   PubMed Web of Science ®Google Scholar